ISS-N1 makes the first FDA-approved drug for spinal muscular atrophy.
- Published in:
- Translational Neuroscience, 2017, v. 8, n. 1, p. 1, doi. 10.1515/tnsci-2017-0001
- By:
- Publication type:
- Article
Works matching IS 20813856 AND DT 2017 AND VI 8 AND IP 1
Results: 1
1